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a b s t r a c t
Rabies is responsible for an estimated 59,000 human deaths worldwide, and domestic dogs are the
primary reservoir and vector of the disease. Among some nations, widespread vaccination has led to
elimination of rabies in domestic dogs, yet dogs are still susceptible to rabies infection from interactions
with wildlife reservoirs. On Tribal lands in the United States, less than 20% of domestic dogs are vacci-
nated for rabies, and parenteral vaccination is often unfeasible. Oral rabies vaccination may provide a
solution, but a suitable bait flavor and vaccine must be identified. We evaluated 5 bait flavors (bacon,
cheese, egg, fish, and sweet) in pairwise flavor-preference trials using placebo Ultralite baits in 26 do-
mestic dogs on the Navajo Nation, Arizona. Each bait flavor was offered a total of 104 times. In all paired
comparisons, bacon was more frequently preferred to the alternative. The sweet flavor (the flavor used
operationally for oral rabies vaccine (ORV) distribution in Canada) was least preferred. Forty domestic
dogs were offered baits containing ONRAB ORV: 14 received the sweet-flavored bait packet and 26
received bacon-flavored baits. Serum was collected from dogs before vaccination and at day 14 and 30 or
37 days after vaccination. Thirty-seven dogs consumed the baits, 2 baits (both sweet flavored) were
chewed and spit out, and 1 (sweet flavored) was swallowed without apparent chewing (gulped). Eight
dogs had preexisting rabies virus neutralizing antibody (RVNA) titers and 13 naïve dogs failed to sero-
convert during the study period. Overall, 27 dogs (67.5%) showed increased RVNA titers after vaccination,
including 1 dog who chewed and spit out the bait and all dogs with positive baseline RVNA titers.
Geometric mean titers for all dogs that seroconverted during the study period peaked at day 14 (1.2 IU/
mL; n ¼ 24) and decreased slightly by the final sampling day (0.8 IU/mL; n ¼ 27). We conclude that bacon
flavor may be a suitable bait flavor for ORV distribution in loosely kept or free-roaming domestic dogs.
Seroconversion among dogs who ingested ONRAB-filled baits was variable. Why 13 dogs who consumed
ORV baits failed to seroconvert remains unknown. Additional research to improve seroconversion rates
in domestic dogs after vaccination with ONRAB is recommended.
Published by Elsevier Inc.
Introduction
Rabies is responsible for an estimated 59,000 human deaths
annually (Hampson et al., 2015; Knobel et al., 2005; Meslin et al.,
2000), and domestic dogs (Canis familiaris) are the primary
terrestrial rabies reservoir and vector globally. Among some
developed nations, widespread vaccination of domestic dogs has
eliminated rabies virus circulation in dogs (Held et al., 1967).
However, even in some areas considered canine rabies free, do-
mestic dogs are still susceptible to infection with variants of
rabies carried by wildlife, at risk to infected dogs imported to the
area (Castrodale et al., 2008; McQuiston et al., 2008;
Windiyaningsih et al., 2004), and populations of feral dogs
exist which are inaccessible or not targeted for parenteral
vaccination (Meslin et al., 2000; Wandeler and Bingham, 2000).
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One method to increase vaccination rates for domestic dogs that
cannot be physically handled may be the distribution of oral
rabies vaccine (ORV; Estrada et al., 2001; Perry et al., 1988; Zhang
et al., 2008).
In the United States, ORV has been used to vaccinate against
rabies in numerous terrestrial wildlife reservoirs including rac-
coons (Procyon lotor), gray foxes (Urocyon cinereoargenteus), and
coyotes (Canis latrans) (Slate et al., 2005, 2009). A 1994 outbreak of
canine rabies in domestic dogs and coyotes resulted in aggressive
vaccination strategies, including ORV (Sidwa et al., 2005), which
ultimately led to the eradication of the domestic dog-coyote variant
of rabies from the United States (Slate et al., 2005, 2009; Velasco-
Villa et al., 2008). It is possible that such applications could be
expanded for use in regions where unvaccinated feral dogs are
abundant and at risk of infection.
There are over 1.6 million dog bite injuries in the United States
every year with the majority occurring in children <15 years of age
(Quirk, 2012). Hospitalizations due to dog bites among people
<20 years of age are nearly twice as high for Native American and
Alaska Native children than for the general US population (Bjork
et al., 2013). In addition, on Tribal Lands in the United States,
<20% of domestic dogs are vaccinated against rabies or any other
disease (Bergman et al., 2008, 2009). During 2013-2015, over 1000
dog bite cases were investigated by the Navajo Nation Animal
Control Program with over 900 outpatient and 500 emergency
room visits reported to local medical facilities (SB, Navajo Nation
Veterinary Program, personal communication). Despite this, there
has not been an indigenous case of human rabies in the United
States associated with the domestic dog-coyote variant reported
since 1994 (Dyer et al., 2014; Petersen and Rupprecht, 2011) and the
last reported case of terrestrial rabies on the Navajo Nation was
in 1949.
Distribution of ORV baits may provide a viable option for
vaccinating free-ranging dogs, but little information exists on
whether domestic dogs will ingest ORV baits and, if so, which bait
flavor would optimize uptake. Bergman et al. (2008) found that,
of 4 commercially produced ORV candidate baits, a fish-flavored
coated sachet had the highest bait consumption among baits
tested. Berentsen et al. (2014a) found domestic dogs consumed
bacon-flavored baits with a similar frequency as a sardine, dog
food, or cheese matrix. However, Bergman et al. (2008) used only
placebo baits and Berentsen et al (2014a) evaluated only the bait
flavor matrix, with no internal vaccine packet. The only ORV
currently licensed for use in wildlife in the United States is
Raboral V-RG (Merial, Ltd., Athens, GA) which has undergone
limited evaluation in domestic dogs. Cliquet et al. (2008) found 12
of 15 naïve dogs survived challenge with rabies virus 28 days after
oral vaccination by Raboral V-RG baits. Rupprecht et al. (2005)
found that 5 of 6 domestic dogs survived challenge with rabies
virus 5 weeks after vaccination by direct instillation into the oral
cavity with an experimental recombinant vaccinia rabies-
glycoprotein.
In Canada, the ONRAB vaccine (Artemis Technologies) is regis-
tered to vaccinate free-ranging striped skunks (Mephitis mephitis)
and is currently under evaluation for use in the United States (Slate
et al., 2014). Research by Knowles et al. (2009) found 100% (4/4) of
domestic dogs seroconverted after direct instillation of ONRAB
vaccine onto the oral cavity, but seroconversion following ingestion
of vaccine-filled baits was not evaluated.
Our objectives were to (1) evaluate preferences among 5 fla-
vors of placebo Ultralite baits (Artemis Technologies, Inc., Guelph,
Ontario, Canada) by domestic dogs to determine which flavors
may be most suitable for ORV delivery to domestic dogs and (2)
use the top-performing Ultralite bait flavor from objective 1 to
deliver ONRAB ORV to domestic dogs and investigate immune
response to vaccination by measuring rabies virus neutralizing
antibody (RVNA) titers.
Materials and methods
We conducted our study at the Navajo Nation Animal Control
Facility on the Navajo Nation, Arizona. Study subjects were mixed-
breed feral dogs captured by animal control officers or dogs
voluntarily surrendered by owners. All dogs were given a physical
examination by a licensed veterinarian (Scott Bender) before in-
clusion in the study. Any dogs showing overt signs of clinical dis-
ease (i.e., canine distemper, etc.) or dogs with medical issues
requiring extensive treatment were excluded. Dogs were housed at
Navajo Nation Animal Control Facility in indoor/outdoor kennels,
fed a daily ration of commercial dry dog food, with water available
ad libitum. A complete description of the study site and animal care
procedures is found in Berentsen et al. (2014a). Vaccination his-
tories for the study subjects were unknown.
The Ultralite bait (Artemis Technologies, Ontario, Canada) used
to deliver the ONRAB vaccine consists of a 30  14  10 mm (1.18 
0.55  0.39 in) elongated blister pack with a waxy external coating.
The coating consists of partially hydrogenated vegetable short-
ening, vegetable oil, food dye, and a food-derived flavoring. Baits
used in flavor-preference trials were placebos containing only wa-
ter. During vaccine trials, each Ultralite bait contained 1.8  0.1 mL
of ONRAB vaccine (titer of 109.5 cell culture infectious dose 50%/
mL). Details on the composition of the bait matrix and vaccine are
previously described (Rosatte et al., 2009).
Flavor-preference trials
We conducted the flavor-preference experiments with 26 dogs
(10 males, 16 females) in 2 trials with 12 and 14 dogs in the first and
second trials, respectively. Five bait matrix flavors were selected for
evaluation (bacon, cheese, sweet, egg, and fish) based on previous
research with domestic dogs (Berentsen et al., 2014a; Bergman
et al., 2008) and coyotes (Berentsen et al., 2014b). Baits were
offered in pairs with each pair combination randomly assigned.
Two bait pairs were offered to each dog each day: one pair in the
morning before feeding and the second pair 6-8 hours later. Each
bait flavor was offered to each dog 4 times with all 10 pair combi-
nations represented for each dog in a balanced randomized block
design.
Vaccine trials
Vaccine-filled baits were offered to 40 dogs (16 m, 24 f), 26 (10
m, 16 f) of which were participants in the flavor-preference trial.
Fourteen (the first trial subjects from objective 1 plus 2 naïve
dogs) received the sweet-flavored bait used operationally for
vaccinating free-ranging skunks and raccoons in Canada (Rosatte
et al., 2009). Twenty-six dogs (the second trial group from
objective 1 plus 12 naïve dogs) received vaccine-filled baits
whose flavor was determined by objective 1. The 14 dogs repur-
posed from objective 1 received vaccine-filled baits following an
approximately 3-month “washout period” following the flavor-
preference trials. The remaining 12 dogs were naïve. A single
vaccine-filled bait was offered to each dog before feeding of their
daily ration. Any bait not consumed within 24 hours was
considered a rejection.
Before vaccination and at days 14 and 30 or 37 after vaccination,
each dog was anesthetized via intramuscular injection of a 0.5-mL
combination of 50-mg Telazol (tiletamine/zolazepam), 40-mg
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ketamine HCl, and 10-mg xylazine, which providedw30minutes of
anesthesia per dog. A blood sample (3-4 mL) was collected via
venipuncture of the cephalic or jugular vein. Blood samples were
centrifuged and the serum transferred to individual cryovials and
frozen at 20C. Samples were shipped to the Rabies Laboratory at
Kansas State University (Manhattan, Kansas). Serologic analysis for
RVNAs was performed using the rapid fluorescent focus inhibition
test (Smith et al. 1996). Titers were converted to IU per mL by
comparison with the US Standard Rabies Immune Globulin diluted
to 2 IU per mL (SRIG, Laboratory of Standards and Testing, Food and
Drug Administration). All dogs with RVNA titers 0.1 IU/mL were
considered seropositive. Dogs with RVNA titers <0.1 IU/mL were
considered seronegative.
Data analysis
Bait preferences
We assumed that each food type had an unknown desirability
score. We therefore calculated the probability that an individual
dog chose food type A over B by the size of the difference between
their scores. We estimated the relative desirability score for each
food type using logistic regression and fitted the probability that
the food type presented on the left was chosen to the difference
between the scores of the food types offered in the left- and right-
hand bowls in an implementation of the Bradley and Terry method
of paired comparison (Bradley and Terry, 1952):
logit

Pj
 ¼ b1*X1j þ b2*X2j þ b3*X3j þ b4*X4j þ b5*X5j
where:
Pj ¼ probability that the left-hand bait flavor was chosen first in
the j-th experiment; coefficient bi is the relative desirability score
for the i-th food type; independent variable Xi ¼ 1 if the i-th bait
flavor is offered on the left; 1 if it is offered on the right; 0 if it is
not offered in the j-th experiment.
Not all dogs ate both baits they were offered. In cases where the
dog only ate 1 bait, that flavor was regarded as preferred; where
none were eaten, the trial was omitted.
The relative sizes of the coefficients gave us a ranking for the
food preferences. However, standard logistic regression does not
take account of difference in preference between individuals so the
standard errors of these coefficients may be underestimated. We
used bootstrapping (Efron, 1981), resampling individuals (rather
than experiments) to yield 1,000 estimates of the ranking. This
allowed us to assign a confidence (or probability) to each of the
more plausible rankings while taking individual differences into
account.
Serological assays
Serologic results were summarized using descriptive statistics
with geometric mean RVNA titer values.
Results
Flavor preference
Each bait flavorwas offered a total of 104 times. Bacon flavor was
eaten more frequently (88/104; 84.6%), followed by cheese (85/104;
81.7%), fish (84/104; 80.7%), egg (83/104; 79.9%), and sweet (56/
104; 53.8%). One dog did not consume any bait. In all paired com-
parisons, bacon was more frequently preferred to the alternative,
cheese was more frequently preferred to the alternative except
bacon; fish was more frequently preferred only to egg and sweet
(Table 1).
Serology
Twenty-six dogs (9 m, 17 f) were offered bacon-flavored vaccine
baits (Table 2). All baits were consumed. Three dogs had preexisting
antibody titers, and all 3 dogs showed increased RVNA titers
following bait consumption. Nine naïve dogs (39%) failed to sero-
convert within the study period (30-37 days), although all 9
consumed a bait. Geometric mean RVNA titers for naïve dogs that
seroconverted by the end of the trial peaked at day 14 (0.9 IU/mL;
range: 0.1-5.0, n ¼ 12) and decreased to 0.7 IU/mL (range: 0.1-2.8,
n ¼ 14) by day 30 or 37 after vaccination (Figure).
Fourteen dogs (7 m, 7 f) were offered the sweet-flavored
vaccine-filled bait: 11 baits were consumed, 2 were chewed and
spit out, and 1 was swallowed without apparent chewing (i.e.,
gulped; Table 2). Five dogs had preexisting antibody titers, but
only 3 of 5 dogs showed increased antibody titer values after
vaccination. Of 7 naïve dogs who consumed baits, 3 (43%) failed to
seroconvert by day 30 after vaccination. The dog that gulped the
bait had a preexisting titer of 1.0 IU/mL, which decreased to 0.3
IU/mL after vaccination. Of the 2 dogs that chewed and spit out
the bait, 1 achieved a maximum titer of 0.1 IU/mL by the final
sampling day and the second remained seronegative. Two baits
were described as “leaking” when offered, although both baits
were consumed and both dogs seroconverted. The amount of
potential vaccine spillage was not recorded. Geometric mean titer
values for the 5 naïve dogs who seroconverted by day 30
(including the dog that chewed and spit out the bait) peaked at
day 14 (0.4 IU/mL; range 0.1-4.2 IU/mL, n ¼ 4) and decreased to
0.2 IU/mL (range: 0.1-2.3 IU/mL, n ¼ 5) by the final sampling
period (Figure).
Discussion
It is interesting to note that sweet-flavored baits were consumed
least by dogs, despite research that suggests canids tend to prefer
sweet-flavored items (Berentsen et al., 2006; Ferrell, 1984; Mason
and McConnell, 1997; Thombre, 2004). However, our results rela-
tive to preference of sweet-flavored baits are consistent with pre-
vious flavor-preference research using Ultralite bait matrix blocks
in domestic dogs (Berentsen et al., 2014a) and placebo ONRAB baits
in coyotes (Berentsen et al., 2014b).
Overall, 26 dogs (67.5%) showed increased RVNA titers after
vaccination, including dogs with positive baseline RVNA titers and 1
dog who chewed but spit out the bait. Why 13 dogs who consumed
baits failed to seroconvert after vaccination remains unknown, but
similar results were found by Cliquet et al. (2008) where 10 of 15
seronegative dogs failed to seroconvert after vaccination. However,
it is important to note that Cliquet et al. (2008) used different RVNA
titer thresholds as well as serologic methods (FAVN vs. rapid fluo-
rescent focus inhibition test) than in this study. Furthermore, failure
to seroconvert may not necessarily indicate lack of protection.
Cliquet et al. (2008) found that although 10 of 15 dogs failed to
Table 1
Bait flavorepreferences likelihoods derived from 1000 bootstrap samples
Ranking Likelihood (%)
Bacon-cheese-fish-egg-sweet 46.1
Bacon-cheese-egg-fish-sweet 40.6
Bacon-egg-cheese-fish-sweet 7.9
Bacon-fish-cheese-egg-sweet 3.2
Bacon-egg-fish-cheese-sweet 1.0
Cheese-bacon-fish-egg-sweet 0.6
Cheese-bacon-egg-fish-sweet 0.4
Bacon-fish-egg-cheese-sweet 0.2
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reach the RVNA titer cutoff established to define seroconversion, 12
of 15 dogs survived challenge. Whether this phenomenon is a result
of the RVNA threshold used to establish seroconversion in the
Cliquet et al. (2008) study is unknown.
Given the results of Knowles et al. (2009) where all dogs sur-
vived challenge following direct instillation of 1.8-mL vaccine, it is
unlikely that the vaccine volume contained within the Ultralite
bait (1.8 mL) was insufficient to stimulate an immune response in
all dogs. It is possible, however, that individual chewing behavior
before swallowing bait was insufficient to allow adequate contact
with the buccal mucosa required for vaccine absorption. It is also
possible but unlikely that given more time, the nonconverters may
have seroconverted, as Aubert (1992) suggested peak immune
response is achieved in dogs 31 days after vaccination. In contrast,
Sattler et al. (2009) suggested optimal timing for detection of
RVNA in wildlife species is approximately 6 weeks after
vaccination.
Our results suggest high variability in immune response among
individual dogs, similar to results found by Aubert (1992) and
Cliquet et al. (2008). It is also interesting to note that while all
bacon-flavored vaccine-filled baits were consumed, 2 of the sweet-
flavored baits were spit out. Future research including direct
instillation of vaccine into the oral cavity to evaluate RVNA titer
response is warranted, asmay be experiments including a challenge
with rabies virus after vaccination to evaluate vaccine efficacy.
Figure. Geometric mean RVNA titer values of dogs seropositive and seronegative
before vaccination. RVNA, rabies virus neutralizing antibody.
Table 2
Consumption and RVNA titer values
ID Bait type Bait fate Virus neutralizing antibody titer (IU/mL)a
Prevaccination Day 14 Day 30/37
11F Sweet Consumed <0.1 <0.1 <0.1
13F Sweet Consumed <0.1 <0.1 <0.1
14M Sweet Consumed <0.1 <0.1 <0.1
2M Sweet Consumed <0.1 0.1 0.1
12M Sweet Consumed <0.1 0.1 0.1
8F Sweet Consumed 0.3 0.2 0.3
9F Sweet Consumed 0.6 0.9 0.6
4F Sweet Consumed 2.3 15.5 13.0
3M Sweet Consumed 27.0 34.0 22.0
1M Sweet Gulped 1.0 0.3 0.3
6M Sweet Leaking sachet/consumed <0.1 0.9 0.3
5M Sweet Leaking sachet/consumed <0.1 4.2 2.3
7F Sweet Chewed, spit out <0.1 <0.1 0.1
10F Sweet Chewed, spit out <0.1 <0.1 <0.1
21M Bacon Consumed <0.1 <0.1 <0.1
23M Bacon Consumed <0.1 <0.1 <0.1
24F Bacon Consumed <0.1 <0.1 <0.1
28F Bacon Consumed <0.1 <0.1 <0.1
29F Bacon Consumed <0.1 <0.1 <0.1b
32M Bacon Consumed <0.1 <0.1 <0.1b
35F Bacon Consumed <0.1 <0.1 <0.1b
37F Bacon Consumed <0.1 <0.1 <0.1b
40M Bacon Consumed <0.1 <0.1 <0.1b
20F Bacon Consumed <0.1 <0.1 0.2
25M Bacon Consumed <0.1 <0.1 2.5
18F Bacon Consumed <0.1 0.1 0.1
22F Bacon Consumed <0.1 0.1 0.3
19F Bacon Consumed <0.1 0.3 0.7
16F Bacon Consumed <0.1 2.2 1.1
15F Bacon Consumed <0.1 0.7 0.8
26F Bacon Consumed <0.1 1.0 2.2
27F Bacon Consumed 0.5 >15.0 >15.0
17M Bacon Consumed 0.6 6.6 8.6
36F Bacon Consumed <0.1 0.5 0.1b
30F Bacon Consumed <0.1 4.3 2.4b
34F Bacon Consumed <0.1 5.0 2.8b
33M Bacon Consumed <0.1 1.7 1.0b
31M Bacon Consumed <0.1 1.7 1.1b
39M Bacon Consumed <0.1 2.0 0.5b
38F Bacon Consumed 0.2 1.5 0.6b
RVNA, rabies virus neutralizing antibody.
a Levels <0.1 IU/mL were considered negative (0).
b Sampled on day 37.
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